Do you hold erdafitinib when treating oligometastatic disease?

If you hold it, how long before and after SABR/SBRT?

Ask a clinical question

Answers grounded in the literature and physician expertise.

Related Questions

Does non-urothelial histology impact your approach to chemoradiotherapy for muscle-invasive bladder cancer?

How do you treat a focal pericardial metastasis?

Would you consider utilizing pembrolizumab/enfortumab as a bladder preservation approach in patients with MIBC?

About Mednet

A community where doctors find answers to medicine's toughest questions.

Verified, credentialed physicians
45,000+ members across 23 specialties
Free CME and MOC credit

Evidence Meets Expertise

Community

Browse Specialties
Code of Conduct
AI Community Guidelines

Tools

Mednet AI
Mobile App

Company

About
Careers
Our Work
Blog

Support

FAQs
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.